medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»medalphabet-838Research ArticleСтатьиГоловные боли и расстройства снаHeadaches and sleep disordersКорешкинаМ. И.KoreshkinaM. ..noemail@neicon.ruЦентр лечения головной боли клиники «Скандинавия»; ООО «АВ-ПЕТЕР»РоссияCentre for the Treatment of Headache of ‘Scandinavia’ Clinic; AVA-PETER CoRussian Federation201801092018327Неврология и психиатрия3035Copyright © Корешкина М.И., 20182018Корешкина М.И.Koreshkina M...Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/838

Эпидемиологические исследования показывают взаимосвязи головных болей и нарушений сна. В статье рассмотрены патофизиологические и поведенческие механизмы развития хронической инсомнии при головной боли. Особое внимание уделено влиянию нарушений сна на первичные головные боли - мигрень и кластерную головную боль. В статье приведены данные по применению мелатонина в комплексном лечении хронических головных болей.

Epidemiological studies show the relationship of headaches and sleep disorders. The article deals with the pathophysiological and behavioral mechanisms of chronic insomnia in headache. Particular attention is paid to the effect of sleep disorders in primary headaches -migraine and cluster headache. The article presents data on using of melatonin in the complex treatment of chronic headaches

расстройства снаголовная больмигренькластерная головная больмелатонинep disordersheadachemigrainecluster headachemelatoninReferencesSteiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z. Migraine is first cause of disability in under50s: will health politicians now take notice? The Journal of Headache and Pain. 2018; 19: 17.Steiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z. Migraine is first cause of disability in under50s: will health politicians now take notice? The Journal of Headache and Pain. 2018; 19: 17.Stranges S, Tigbe W, Gomes-Olive F, Thorogood M, Kandala N. Sleep problems: an emerging global epidemic? Findings from the INDEPTH WHO-SAGE study among more than 40,000 older adults from 8 countries across Africa and Asia. Sleep. 2012, 35 (8): 1173-1181.Stranges S, Tigbe W, Gomes-Olive F, Thorogood M, Kandala N. Sleep problems: an emerging global epidemic? Findings from the INDEPTH WHO-SAGE study among more than 40,000 older adults from 8 countries across Africa and Asia. Sleep. 2012, 35 (8): 1173-1181.Living E. On megrim, sick headache, and some allied disorders. London: Churchill, 1873.Living E. On megrim, sick headache, and some allied disorders. London: Churchill, 1873.Romberg M. A manual of the nervous diseases of man. London: Sydenham Society, 1853.Romberg M. A manual of the nervous diseases of man. London: Sydenham Society, 1853.Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018; 38 (1): 1-211.Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018; 38 (1): 1-211.American Sleep Disorders Association. Diagnostic Classification Steering Committee. International classification of sleep disorders: diagnostic and coding manual. Westchester. American Academy of Sleep Medicine. 2005.American Sleep Disorders Association. Diagnostic Classification Steering Committee. International classification of sleep disorders: diagnostic and coding manual. Westchester. American Academy of Sleep Medicine. 2005.Philip R. Holland Headache and sleep: Shared pathophysiological mechanisms. Cephalalgia. 2014; 34 (10): 725-744.Philip R. Holland Headache and sleep: Shared pathophysiological mechanisms. Cephalalgia. 2014; 34 (10): 725-744.Gotter AL, Roecker AJ, Hargreaves R, Coleman PJ, Winrow CJ, Renger IJ. Orexin receptors as therapeutic drug targets. Prog Brain Res. 2012; 198: 163-188.Gotter AL, Roecker AJ, Hargreaves R, Coleman PJ, Winrow CJ, Renger IJ. Orexin receptors as therapeutic drug targets. Prog Brain Res. 2012; 198: 163-188.Holland PR and Goadsby PJ. The hypothalamic orexinergic system: Pain and primary headaches. Headache. 2007; 47: 951-962.Holland PR and Goadsby PJ. The hypothalamic orexinergic system: Pain and primary headaches. Headache. 2007; 47: 951-962.Robert C, Bourgeais L, Arreto C-D, Condes-Lara M, Noseda R, Jay T, Villanueva L. Paraventricular hypothalamic regulation of trigeminovascularmechanisms involved in headaches. J Neurosc. 2013; 33:8827-8840.Robert C, Bourgeais L, Arreto C-D, Condes-Lara M, Noseda R, Jay T, Villanueva L. Paraventricular hypothalamic regulation of trigeminovascularmechanisms involved in headaches. J Neurosc. 2013; 33:8827-8840.Goadsby P. J. Putting migraine to sleep: Rexants as a preventive strategy. Cephalalgia. 2015; 35 (5): 377-378.Goadsby P. J. Putting migraine to sleep: Rexants as a preventive strategy. Cephalalgia. 2015; 35 (5): 377-378.Ong J, Park M. Chronic headaches and insomnia: Working toward a biobehavioral model. Cephalalgia. 2012; 32 (14): 1059-1070.Ong J, Park M. Chronic headaches and insomnia: Working toward a biobehavioral model. Cephalalgia. 2012; 32 (14): 1059-1070.Evers S. Special Issue on Headache and Sleep. Cephalalgia. 2014; 34 (10): 723-724.Evers S. Special Issue on Headache and Sleep. Cephalalgia. 2014; 34 (10): 723-724.Lund N, Westergaard ML, Barloese M, Glumerand S, Jensen R. Epidemilogy of concurrent headache and sleep problems in Denmark. Cephalalgia. 2014; 34 (10): 833-845.Lund N, Westergaard ML, Barloese M, Glumerand S, Jensen R. Epidemilogy of concurrent headache and sleep problems in Denmark. Cephalalgia. 2014; 34 (10): 833-845.Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007; 27: 394-402.Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007; 27: 394-402.Bigal ME, Lipton RB. Modifiable risk factors for migraine progression. Headache. 2006; 46: 1334-1343.Bigal ME, Lipton RB. Modifiable risk factors for migraine progression. Headache. 2006; 46: 1334-1343.Morgan I, Eguia F, Gelaye B, Peterlin B, Tadesse M, Lemma S, Berhane Y, Williams M. Sleep disturbances and quality of life in Sub-Saharan African migraineurs. The Journal of Headache and Pain. 2015; 16: 18.Morgan I, Eguia F, Gelaye B, Peterlin B, Tadesse M, Lemma S, Berhane Y, Williams M. Sleep disturbances and quality of life in Sub-Saharan African migraineurs. The Journal of Headache and Pain. 2015; 16: 18.Song T-J, Yin CH, Cho SI, Yang KI, Chu MK. Short sleep duration and poor sleep quality among migraineurs. A population based study. Cephalalgia. 2018; 38 (5): 855-864.Song T-J, Yin CH, Cho SI, Yang KI, Chu MK. Short sleep duration and poor sleep quality among migraineurs. A population based study. Cephalalgia. 2018; 38 (5): 855-864.Fischera M. Marziniak M, Gralow I, Evers S. The incidence and prevalence of cluster headache: A meta-analysis of population-based studies. Cephalalgia. 2008; 28: 614-668.Fischera M. Marziniak M, Gralow I, Evers S. The incidence and prevalence of cluster headache: A meta-analysis of population-based studies. Cephalalgia. 2008; 28: 614-668.Holle D, Naegel S, Krebs Z, Diener HC, Gaul C, Oberman M. Clinical characteristics and therapeutic options in hypnic headache. Cephalalgia. 2010; 30: 1435-1442.Holle D, Naegel S, Krebs Z, Diener HC, Gaul C, Oberman M. Clinical characteristics and therapeutic options in hypnic headache. Cephalalgia. 2010; 30: 1435-1442.Engstr0m M et al. Sleep-related and non-sleep-related migraine: interictal sleep quality, arousals and pain thresholds// The Journal of Headache and Pain 2013, 14: 68.Engstr0m M et al. Sleep-related and non-sleep-related migraine: interictal sleep quality, arousals and pain thresholds// The Journal of Headache and Pain 2013, 14: 68.Krisoffersen ES, Stavem K, Lundqvist C, Russel MB. Excessive daytime sleepiness in chronic migraine and chronic tension-type headache from general population. Cephalalgia. 2018; 38 (5): 993-997.Krisoffersen ES, Stavem K, Lundqvist C, Russel MB. Excessive daytime sleepiness in chronic migraine and chronic tension-type headache from general population. Cephalalgia. 2018; 38 (5): 993-997.BorisenkovM, Petrova N, Kasyanova O. Sleep characteristics, chronotype and winter depression in 10-20-year-olds in northern European Russia. Journal of Sleep Research. 2015; 24: 288-295.BorisenkovM, Petrova N, Kasyanova O. Sleep characteristics, chronotype and winter depression in 10-20-year-olds in northern European Russia. Journal of Sleep Research. 2015; 24: 288-295.Wang Y, Xie J, Yang F, Wu S, Wang H, Zhang X, Liu H, Deng X, Xie W. Comorbidity of poor sleep and primary headaches among nursing staff in north China. The Journal of Headache and Pain. 2015: 16: 88.Wang Y, Xie J, Yang F, Wu S, Wang H, Zhang X, Liu H, Deng X, Xie W. Comorbidity of poor sleep and primary headaches among nursing staff in north China. The Journal of Headache and Pain. 2015: 16: 88.Peres MF, Zukerman E, da Cunha TanuriF, Moreira FR, Cipolla-NettoJ. Melatonin, 3 mg, is effective for migraine prevention. Neurology. 2004; 63 (4): 757.Peres MF, Zukerman E, da Cunha TanuriF, Moreira FR, Cipolla-NettoJ. Melatonin, 3 mg, is effective for migraine prevention. Neurology. 2004; 63 (4): 757.Nagtegaal JE, Smits MG, Kerkhov GA, van der Meer YG. Melatonin responsive headache in delayed sleep phase syndrome: preliminary observations. Headache. 1998; 38 (4): 303-307.Nagtegaal JE, Smits MG, Kerkhov GA, van der Meer YG. Melatonin responsive headache in delayed sleep phase syndrome: preliminary observations. Headache. 1998; 38 (4): 303-307.Bougea A, Spantideas N, Lyras V, Avrimidis, Thomaidis T. Melatonin 4 mg as prophylactic therapy for primary headaches: a pilot study. Functional neurology. 2016: 1-5.Bougea A, Spantideas N, Lyras V, Avrimidis, Thomaidis T. Melatonin 4 mg as prophylactic therapy for primary headaches: a pilot study. Functional neurology. 2016: 1-5.Курганова ЮМ, Данилов АМ. Мелатонин при боли в спине и предикторы его эффективности. Журнал неврологии и психиатрии. 2017; 10: 49-54.Курганова ЮМ, Данилов АМ. Мелатонин при боли в спине и предикторы его эффективности. Журнал неврологии и психиатрии. 2017; 10: 49-54.Gonçalves AL, Martini Ferreira A, Zukerman E, Cipolla-Neto J, Pres MF. Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention. J Neurol Neurosurg Psychiatry. 2016; 87 (10): 1127-1132.Gonçalves AL, Martini Ferreira A, Zukerman E, Cipolla-Neto J, Pres MF. Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention. J Neurol Neurosurg Psychiatry. 2016; 87 (10): 1127-1132.

The authors declare that there are no conflicts of interest present.